COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey

202218 citationsJournal Articlehybrid Open Access

Authors

Leonardo Santos Hoff · Universidade Potiguar

R Naveen · Sanjay Gandhi Post Graduate Institute of Medical Sciences

Samuel Katsuyuki Shinjo · Universidade de São Paulo

Jessica Day · The Royal Melbourne Hospital

Parikshit Sen · Maulana Azad Medical College

Jucier Gonçalves Júnior · Universidade de São Paulo

James B Lilleker

Abstract

Patients with IIMs reported fewer COVID-19 cases than HCs and other SAIDs, but had higher odds of all-cause hospitalization from COVID-19 than HCs. BIs were associated with the use of immunosuppressants and were uncommon in IIMs.

Topics & Keywords

T-cell and B-cell Immunology Peripheral Neuropathies and Disorders SARS-CoV-2 and COVID-19 Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Rheumatology International

Volume 43, Issue 1, pp. 47-58

DOI: 10.1007/s00296-022-05229-7

Field-Weighted Citation Impact: 1.53